Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Streetinsider.com's Hot Lunchtime Reads 7/11: (WMT) (MDCO) (MMS) (PSTI)
-
Maxim Group Reiterates Buy on Pluristem Therapeutics (PSTI) Following Announced Contract with Global CRO
-
Pluristem Therapeutics (PSTI) PT Cut to $3 at Maxim Group; 'Buy' Maintained
-
Pluristem Therapeutics (PSTI) Prices 6.8M Common Stock, Warrants Direct Offering at $2.50/Unit
-
Pluristem Therapeutics Announces Pricing of Registered Direct Offering of Common Stock and Warrants
-
Pluristem Therapeutics Announces Pricing of Registered Direct Offering of Common Stock and Warrants
-
Maxim Group Upgrades Pluristem Therapeutics (PSTI) to Buy
-
Maxim Group Downgrades Pluristem Therapeutics (PSTI) to Hold
-
Underwriters Exercise Full 1.2M Overallotment in Pluristem (PSTI) Common Offering
-
Pluristem Therapeutics (PSTI) Closes 8M Common Offering at $4/Unit
-
Pluristem (PSTI) Announces Common, Warrants Offering

